Physician profile
Thomas Freeman
NPI 1235178088
$7,520.49
in general payments reported to CMS, 2019-2025
18 companies · $62.46 in 2025
The $62.46 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,160 · 2020: $74.64 · 2021: $13.33 · 2022: $59.67 · 2023: $74.51 · 2024: $75.68 · 2025: $62.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $7,000.00 | 2019 | |
| Paragon 28, INC. | $109.14 | 2019 | |
| Medtronic, INC. | $78.71 | 2024-2025 | Intellis Adaptivestim, Venaseal |
| Zimmer Biomet Holdings, INC. | $48.99 | 2020 | |
| Stryker Corporation | $29.43 | 2023 | Citrefix, Ortholoc 2 Lapifuse, Ortholoc 3di |
| Smith+Nephew, INC. | $28.15 | 2022 | |
| Bioventus LLC | $26.47 | 2019-2021 | |
| Tactile Systems Technology INC | $26.42 | 2019 | |
| Globus Medical, INC. | $25.09 | 2025 | Senza |
| Abbott Laboratories | $23.32 | 2023 | Proclaim |
| Orthofix Medical, INC. | $21.76 | 2023 | Physio-Stim |
| Kerecis Limited | $18.19 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $18.09 | 2022 | |
| Mimedx Group, INC. | $16.15 | 2025 | |
| Arthrosurface Incorporated | $14.55 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $13.43 | 2022 | |
| Reprise Biomedical, INC. | $11.50 | 2019 | |
| Zyla Life Sciences, INC. | $11.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.